Key Highlights

  • France and Germany proposed giving the European Commission wider powers to retaliate against disproportionate trade measures on October 5.
  • China's trade surplus with the European Union has widened from about 0.6 percent of the bloc's GDP in 2000 to roughly 2 percent today.
  • A stress test of 56 pharmaceutical active ingredients found that disruption to Chinese supplies would cause severe consequences for 20 of them.
  • Over 70 percent of precursor chemicals for a common antibiotic are sourced from China, according to the stress test findings.

A Widening Trade Imbalance Prompts Renewed Policy Debate

The European Union's trade relationship with China has grown increasingly imbalanced over the past two and a half decades. China's trade surplus with the bloc stood at approximately 0.6 percent of GDP in 2000, the year before China joined the World Trade Organization. That surplus has since widened to roughly 2 percent of GDP, equivalent to close to 1 billion dollars a day in net flows.

France and Germany, the bloc's two largest economies, have historically taken different approaches to managing this imbalance, with France favoring trade barriers and Germany favoring continued engagement given its manufacturing exposure to the Chinese market. A joint letter sent to the European Commission on October 5 proposes a shift toward a more unified stance, granting Brussels expanded authority to respond when trading partners retaliate disproportionately against EU trade measures.

Supply Chain Dependencies Complicate the Policy Response

The proposal follows a period in which China imposed export restrictions on rare earth materials, a move that affected European defense manufacturers among other industries reliant on these inputs. European officials have described the new measures as a deterrent intended to discourage similar restrictions in the future, though the letter does not name China directly.

European industry's dependence on Chinese inputs extends beyond rare earths. A stress test conducted in April by the EU Institute for Security Studies examined 56 active pharmaceutical ingredients and their precursor chemicals, finding that disruption to Chinese supply would cause severe consequences for 20 of them. Precursor chemicals for a widely used antibiotic are sourced from China in a proportion exceeding 70 percent.

Balancing Retaliatory Tools Against Supply Diversification Needs

The effectiveness of expanded retaliatory powers may depend on the extent to which the European Union also reduces its reliance on Chinese supply chains. China continues to depend on European inputs in select areas, including Dutch chipmaking equipment and aircraft components, which creates a degree of mutual dependency between the two economies.

Broader trade diversification, including expanded agreements with countries that supply rare earth materials, represents one path under discussion alongside the retaliatory framework. The balance between deterrent trade tools and structural supply chain changes remains a central point of discussion among EU member states ahead of a scheduled summit.

Summit Outcome and Supply Chain Metrics to Watch

European leaders are scheduled to decide on the Franco-German proposal at a summit on October 15. Metrics worth monitoring include any additional rare earth export measures from China, the pace of EU efforts to diversify sourcing for pharmaceutical precursors and critical minerals, and whether member states beyond France and Germany align with the proposed expansion of the Commission's retaliatory authority.